FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2158756209> ?p ?o ?g. }

• W2158756209 endingPage "146" @default.
• W2158756209 startingPage "142" @default.
• W2158756209 abstract "Purpose Paclitaxel is considered to be suitable for disseminated cancer in the peritoneal cavity because of its high molecular weight and lipophilic characteristics. However, the difference in pharmacokinetics of paclitaxel after intraperitoneal (i.p.) and intravenous (i.v.) administration is not fully defined. Here, we investigated the tissue concentration of paclitaxel in various organs at various time points after i.p. or i.v. administration. Methods Paclitaxel (5 mg/kg) was administrated in an ear vein or in the abdominal cavity of rabbits. At 0.5, 6, 24, and 48 h after administration, the rabbits were sacrificed, and organs as well as peripheral blood were harvested. The serum and tissue concentrations of paclitaxel were measured by HPLC procedure. Result The concentration of paclitaxel was high in the i.v. group at 0.5 h, whereas it was significantly higher in the i.p. group at 6 and 24 h. The AUC (area under the curve) was markedly higher in the omentum, mesenteric lymph nodes as well as ovary and stomach in the i.p. group. Conclusion Compared with i.v. administration, paclitaxel concentration was maintained at a high level in the whole body by i.p. administration. Repeated i.p. paclitaxel can produce more marked clinical effects than i.v. administration for metastatic lymph nodes and primary lesions as well as peritoneal dissemination. Paclitaxel is considered to be suitable for disseminated cancer in the peritoneal cavity because of its high molecular weight and lipophilic characteristics. However, the difference in pharmacokinetics of paclitaxel after intraperitoneal (i.p.) and intravenous (i.v.) administration is not fully defined. Here, we investigated the tissue concentration of paclitaxel in various organs at various time points after i.p. or i.v. administration. Paclitaxel (5 mg/kg) was administrated in an ear vein or in the abdominal cavity of rabbits. At 0.5, 6, 24, and 48 h after administration, the rabbits were sacrificed, and organs as well as peripheral blood were harvested. The serum and tissue concentrations of paclitaxel were measured by HPLC procedure. The concentration of paclitaxel was high in the i.v. group at 0.5 h, whereas it was significantly higher in the i.p. group at 6 and 24 h. The AUC (area under the curve) was markedly higher in the omentum, mesenteric lymph nodes as well as ovary and stomach in the i.p. group. Compared with i.v. administration, paclitaxel concentration was maintained at a high level in the whole body by i.p. administration. Repeated i.p. paclitaxel can produce more marked clinical effects than i.v. administration for metastatic lymph nodes and primary lesions as well as peritoneal dissemination." @default.
• W2158756209 created "2016-06-24" @default.
• W2158756209 creator A5012171554 @default.
• W2158756209 creator A5040731065 @default.
• W2158756209 creator A5059967481 @default.
• W2158756209 creator A5079919434 @default.
• W2158756209 creator A5091178846 @default.
• W2158756209 date "2009-07-01" @default.
• W2158756209 modified "2023-09-30" @default.
• W2158756209 title "Different Tissue Distribution of Paclitaxel With Intravenous and Intraperitoneal Administration" @default.
• W2158756209 cites W1871865048 @default.
• W2158756209 cites W1922469696 @default.
• W2158756209 cites W1965002318 @default.
• W2158756209 cites W1987162625 @default.
• W2158756209 cites W2011447881 @default.
• W2158756209 cites W2015167754 @default.
• W2158756209 cites W2027998636 @default.
• W2158756209 cites W2031744300 @default.
• W2158756209 cites W2037490361 @default.
• W2158756209 cites W2037605675 @default.
• W2158756209 cites W2040444575 @default.
• W2158756209 cites W2044221999 @default.
• W2158756209 cites W2061420491 @default.
• W2158756209 cites W2066522045 @default.
• W2158756209 cites W2092343484 @default.
• W2158756209 cites W2154175915 @default.
• W2158756209 cites W2158795107 @default.
• W2158756209 cites W2158841682 @default.
• W2158756209 cites W2262251960 @default.
• W2158756209 cites W2333188198 @default.
• W2158756209 cites W3039052488 @default.
• W2158756209 cites W4255152173 @default.
• W2158756209 doi "https://doi.org/10.1016/j.jss.2008.06.049" @default.
• W2158756209 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19328496" @default.
• W2158756209 hasPublicationYear "2009" @default.
• W2158756209 type Work @default.
• W2158756209 sameAs 2158756209 @default.
• W2158756209 citedByCount "38" @default.
• W2158756209 countsByYear W21587562092012 @default.
• W2158756209 countsByYear W21587562092013 @default.
• W2158756209 countsByYear W21587562092014 @default.
• W2158756209 countsByYear W21587562092015 @default.
• W2158756209 countsByYear W21587562092016 @default.
• W2158756209 countsByYear W21587562092017 @default.
• W2158756209 countsByYear W21587562092018 @default.
• W2158756209 countsByYear W21587562092019 @default.
• W2158756209 countsByYear W21587562092021 @default.
• W2158756209 countsByYear W21587562092022 @default.
• W2158756209 countsByYear W21587562092023 @default.
• W2158756209 crossrefType "journal-article" @default.
• W2158756209 hasAuthorship W2158756209A5012171554 @default.
• W2158756209 hasAuthorship W2158756209A5040731065 @default.
• W2158756209 hasAuthorship W2158756209A5059967481 @default.
• W2158756209 hasAuthorship W2158756209A5079919434 @default.
• W2158756209 hasAuthorship W2158756209A5091178846 @default.
• W2158756209 hasConcept C110121322 @default.
• W2158756209 hasConcept C112705442 @default.
• W2158756209 hasConcept C121608353 @default.
• W2158756209 hasConcept C126322002 @default.
• W2158756209 hasConcept C134306372 @default.
• W2158756209 hasConcept C141071460 @default.
• W2158756209 hasConcept C142724271 @default.
• W2158756209 hasConcept C2777292972 @default.
• W2158756209 hasConcept C2778536324 @default.
• W2158756209 hasConcept C2779422922 @default.
• W2158756209 hasConcept C2779720271 @default.
• W2158756209 hasConcept C2780427987 @default.
• W2158756209 hasConcept C2780936613 @default.
• W2158756209 hasConcept C33923547 @default.
• W2158756209 hasConcept C71924100 @default.
• W2158756209 hasConcept C76318530 @default.
• W2158756209 hasConcept C98274493 @default.
• W2158756209 hasConceptScore W2158756209C110121322 @default.
• W2158756209 hasConceptScore W2158756209C112705442 @default.
• W2158756209 hasConceptScore W2158756209C121608353 @default.
• W2158756209 hasConceptScore W2158756209C126322002 @default.
• W2158756209 hasConceptScore W2158756209C134306372 @default.
• W2158756209 hasConceptScore W2158756209C141071460 @default.
• W2158756209 hasConceptScore W2158756209C142724271 @default.
• W2158756209 hasConceptScore W2158756209C2777292972 @default.
• W2158756209 hasConceptScore W2158756209C2778536324 @default.
• W2158756209 hasConceptScore W2158756209C2779422922 @default.
• W2158756209 hasConceptScore W2158756209C2779720271 @default.
• W2158756209 hasConceptScore W2158756209C2780427987 @default.
• W2158756209 hasConceptScore W2158756209C2780936613 @default.
• W2158756209 hasConceptScore W2158756209C33923547 @default.
• W2158756209 hasConceptScore W2158756209C71924100 @default.
• W2158756209 hasConceptScore W2158756209C76318530 @default.
• W2158756209 hasConceptScore W2158756209C98274493 @default.
• W2158756209 hasIssue "1" @default.
• W2158756209 hasLocation W21587562091 @default.
• W2158756209 hasLocation W21587562092 @default.
• W2158756209 hasOpenAccess W2158756209 @default.
• W2158756209 hasPrimaryLocation W21587562091 @default.
• W2158756209 hasRelatedWork W1485898139 @default.
• W2158756209 hasRelatedWork W1540839883 @default.
• W2158756209 hasRelatedWork W1982777678 @default.
• W2158756209 hasRelatedWork W1990964652 @default.

• next